ALUME BIOSCIENCES, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
4
Active:0
Completed:1
Trial Phases
3 Phases
Phase 1:1
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (50.0%)Phase 1
1 (25.0%)Phase 3
1 (25.0%)A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery
- First Posted Date
- 2024-10-28
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Alume Biosciences, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT06662097
- Locations
- 🇺🇸
University of California San Diego, San Diego, California, United States
Feasibility Study for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery
Phase 2
Recruiting
- Conditions
- Head and Neck Surgery
- Interventions
- Device: REVEAL 475 System
- First Posted Date
- 2024-01-29
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Alume Biosciences, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT06227585
- Locations
- 🇺🇸
Jacobs Medical Center at UC San Diego Health, San Diego, California, United States
Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery
Phase 3
Recruiting
- Conditions
- Surgery
- Interventions
- Other: Intra-operative Visualization using White Light Reflectance (WLR)Other: Intraoperative Visualization using White Light Reflectance (WLR) with Fluorescence (FL) Overlay
- First Posted Date
- 2022-05-17
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Alume Biosciences, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT05377554
- Locations
- 🇺🇸
University of California San Diego, La Jolla, California, United States
Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery
Phase 1
Completed
- Conditions
- SurgeryNerve InjuryImagingThyroid NeoplasmsParotid NeoplasmHead and Neck Neoplasms
- Interventions
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Alume Biosciences, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT04420689
- Locations
- 🇺🇸
University of California San Diego, San Diego, California, United States
🇺🇸Stanford University, Stanford, California, United States
🇺🇸Harvard-Mass Eye & Ear, Boston, Massachusetts, United States
News
No news found